✦ LIBER ✦

Calvacin: A New Antitumor Agent

✍ Scribed by Roland, J. F.; Chmielewicz, Z. F.; Weiner, B. A.; Gross, A. M.; Boening, O. P.; Luck, J. V.; Bardos, T. J.; Reilly, H. C.; Sugiura, K.; Stock, C. C.; Lucas, E. H.; Byerrum,, R. U.; Stevens, J. A.

Book ID: 121166736
Publisher: American Association for the Advancement of Science
Year: 1960
Tongue: English
Weight: 272 KB
Volume: 132
Category: Article
ISSN: 0036-8075
DOI: 10.1126/science.132.3443.1897

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tiazofurin: A new antitumor agent

✍ Peter J. O'Dwyer; D. Dale Shoemaker; Hiremagalur N. Jayaram; David G. Johns; Dav 📂 Article 📅 1984 🏛 Springer US 🌐 English ⚖ 481 KB

Tiazofurin is an interesting drug now entering Phase I trials, with marked preclinical antitumor activity against P388 and L1210 leukemias, and the Lewis lung carcinoma. Schedule dependency favoring frequent administration has been noted. The drug has a novel mechanism of action, being metabolized

New antitumor agent — Spirobromin

✍ T. S. Safonova; V. A. Chernov; S. M. Minakova; M. I. Dorokhova; L. G. Levkovskay 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 265 KB

9-Deazaadenosine—A new potent antitumor

9-Deazaadenosine—A new potent antitumor agent

✍ Ming Y. Chu; Linda B. Zuckerman; Seiji Sato; Gerald W. Crabtree; Arthur E. Bogde 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 764 KB

Quadrone, a new antitumor agent from asp

Quadrone, a new antitumor agent from aspergillus terreus

✍ R.L. Ranieri; G.J. Calton 📂 Article 📅 1978 🏛 Elsevier Science 🌐 French ⚖ 182 KB

Clastogenic activity of FK973, a new ant

Clastogenic activity of FK973, a new antitumor agent

✍ Y. Miyamae; O. Hirai; K. Ohara; M. Hashimoto; A. Tensho 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Experimental antitumor activity of BMY-2

Experimental antitumor activity of BMY-28175 a new fermentation derived antitumor agent

✍ John E. Schurig; William C. Rose; Hideo Kamei; Yuji Nishiyama; William T. Bradne 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 586 KB

BMY-28175 is a novel antitumor antibiotic produced in fermentation by Actinomadura verrucosospora. The cytotoxic effects of BMY-28175 were determined using murine and human tumor cell lines in vitro. Following 72 hour exposure, the drug had IC50 values 1.5 to 13.5 ng/ml in a microtiter assay. BMY-28